Carysil Q2 Results Review - Steady Show, Demand To Accelerate From Hereon; Reaffirm 'Buy': Yes Securities

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy..Yes Securities Report.We remain confident on Carysil Ltd.’s growth owing to improvement in U.S. and Europe business and company expanding its presence in newer geographies. Moreover, with on-boarding of new clients and a higher share from existing customers will boost overall topline. Also, newer capacities across segments will enable the company to cater the growing demand. On consolidated basis we expect top-line to grow by 19% compound annual growth rate over FY24-FY27E to Rs 11.58 billion and operating margins should remain at 18.4% in FY27E. Hence, Ebitda is likely to grow by 18% CAGR over FY24-FY27E. With the reduction in debt, we expect PAT to grow faster at 26% CAGR over similar period. At current market price, the stock trades at P/E(x) of 24.3x/19.6x on FY26E/FY27E EPS of Rs 33.4/41.4 respectively. We continue to value the company at P/E(x) of 25x on FY27E EPS, arriving at a target price of Rs 1,035 (adjusted for revised share capital). Hence, we reaffirm our Buy rating on the stock..Click on the attachment to read the full report:.Biocon - 'VAI’ Brings Much-Needed Regulatory Respite, Says Motilal Oswal.DISCLAIMERThis report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit..Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Carysil Q2 Results Review - Steady Show, Demand To Accelerate From Hereon; Reaffirm 'Buy': Yes Securities

Newer capacities across segments will enable the company to cater the growing demand, says the brokerage.

NDTV Profit

NDTV Profit

Follow Us

DOWNLOAD THE APP

Carysil Q2 Results Review - Steady Show, Demand To Accelerate From Hereon; Reaffirm 'Buy': Yes Securities

Newer capacities across segments will enable the company to cater the growing demand, says the brokerage.

Choose a plan

Follow Us

DOWNLOAD THE APP